<DOC>
	<DOCNO>NCT01050348</DOCNO>
	<brief_summary>This double-blinded randomized placebo control trial investigate role upstream 80mg Atorvastastin-calcium patient undergo percutaneous intervention acute STEMI .</brief_summary>
	<brief_title>To Investigate Role Upstream High Dose Statin STEMI</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>1 . Any patient 25 90 year age admit transferred Western Pennsylvania Hospital Allegheny General Hospital diagnosis STEMI undergoing emergent percutaneous intervention ( PCI ) culprit coronary artery . STEMI define great 1mm ST segment elevation electrocardiogram . 2 . Elevated cardiac biomarkers ( troponinT &gt; 0.03ng/ml , CKMB &gt; 5ng/mL , ck &gt; 170 U/l ) . 1 . Known history liver disease define cirrhosis , alcoholic liver disease , Non alcoholic steatohepatitis , hepatitis cause liver failure . 2 . Renal failure creatinine &gt; 3mg/dL 3 . Known history liver muscle disease rheumatologic myopathy , history myositis , hepatitis , hepatic cancer . 4 . Cardiovascular arrest shock .</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>